glucagon has been researched along with lysophosphatidylcholines in 9 studies
Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (lysophosphatidylcholines) | Trials (lysophosphatidylcholines) | Recent Studies (post-2010) (lysophosphatidylcholines) |
---|---|---|---|---|---|
26,039 | 1,498 | 3,054 | 5,058 | 39 | 976 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (77.78) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Houslay, MD; Palmer, RW | 1 |
Carrea, G; Pasta, P; Vecchio, G | 1 |
Edelhoch, H; Schneider, AB | 3 |
Armston, AE; Halestrap, AP | 1 |
Hamed, MM; Mattice, WL; Robinson, RM | 1 |
Ferrari, LE; Hulsmann, WC; Peschechera, A; Serafini, F | 1 |
Hauser, R; Li, M; Pohl, R; Steiner, SS | 1 |
9 other study(ies) available for glucagon and lysophosphatidylcholines
Article | Year |
---|---|
Lysophosphatidylcholines can modulate the activity of the glucagon-stimulated adenylate cyclase from rat liver plasma membranes.
Topics: Adenylyl Cyclase Inhibitors; Animals; Cell Membrane; Fluorides; Glucagon; In Vitro Techniques; Liver; Lysophosphatidylcholines; Male; Rats | 1979 |
Conformation and proteolysis of glucagon and insulin in surfactant and lipid solutions.
Topics: Anions; Cations; Cetrimonium; Cetrimonium Compounds; Chromatography, High Pressure Liquid; Chymotrypsin; Circular Dichroism; Glucagon; Hydrolysis; Insulin; Lipids; Lysophosphatidylcholines; Protein Conformation; Sodium Dodecyl Sulfate; Solutions; Surface-Active Agents; Trypsin | 1988 |
Polypeptide hormone interaction. II. Glucagon binding to lysolecithin.
Topics: Adrenocorticotropic Hormone; Aniline Compounds; Animals; Calcitonin; Cattle; Colloids; Fluorescent Dyes; Glucagon; Hydrogen-Ion Concentration; Kinetics; Lysophosphatidylcholines; Macromolecular Substances; Naphthalenes; Phosphatidylcholines; Phosphatidylethanolamines; Protein Binding; Spectrometry, Fluorescence; Sulfonic Acids; Swine; Tryptophan | 1972 |
Polypeptide hormone interaction. 3. Conformational changes of glucagon bound to lysolecithin.
Topics: Adrenocorticotropic Hormone; Calcitonin; Circular Dichroism; Colloids; Glucagon; Histidine; Hydrogen-Ion Concentration; Lysophosphatidylcholines; Macromolecular Substances; Peptides; Protein Binding; Protein Conformation; Spectrometry, Fluorescence; Spectrophotometry; Trypsin; Tyrosine; Ultraviolet Rays | 1972 |
Conformational changes of protected glucagon fragments bound to lysolecithin.
Topics: Adenylyl Cyclases; Animals; Binding Sites; Butanols; Cell Membrane; Chromatography, Thin Layer; Circular Dichroism; Enzyme Activation; Glucagon; Liver; Lysophosphatidylcholines; Oligopeptides; Protein Conformation; Rats; Spectrometry, Fluorescence | 1973 |
Glucagon treatment of rats inhibits the accumulation of lysophospholipids by liver mitochondria during preparation and subsequent incubation.
Topics: Animals; Female; Glucagon; Kinetics; Lysophosphatidylcholines; Lysophospholipids; Mitochondria, Liver; Phosphatidylethanolamines; Phospholipids; Phosphorus Radioisotopes; Rats; Rats, Inbred Strains | 1984 |
Behavior of amphipathic helices on analysis via matrix methods, with application to glucagon, secretin, and vasoactive intestinal peptide.
Topics: Gastrointestinal Hormones; Glucagon; Lysophosphatidylcholines; Protein Conformation; Secretin; Vasoactive Intestinal Peptide | 1983 |
Release of ischemia in paced rat Langendorff hearts by supply of L-carnitine: role of endogenous long-chain acylcarnitine.
Topics: Aerobiosis; Animals; Cardiac Pacing, Artificial; Carnitine; Cations; Cell Membrane; Cells, Cultured; Endothelium, Vascular; Glucagon; Glycerol; Heart; Lactates; Lactic Acid; Lipolysis; Lysophosphatidylcholines; Male; Myocardial Ischemia; Organ Culture Techniques; Perfusion; Rats; Rats, Wistar; Uric Acid | 1996 |
Stabilized glucagon formulation for bihormonal pump use.
Topics: Alcohols; Buffers; Carbohydrates; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Stability; Glucagon; Hydrogen-Ion Concentration; Insulin Infusion Systems; Lysophosphatidylcholines; Pharmaceutical Solutions; Reducing Agents; Temperature; Time Factors | 2010 |